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Abstract
It is of interest to define bacterial toxin biochemical properties to use them as molecular-syringe devices in order to deliver
enzymatic activities into host cells. Binary toxins of the AB7/8-type are among the most potent and specialized bacterial
protein toxins. The B subunits oligomerize to form a pore that binds with high affinity host cell receptors and the enzymatic
A subunit. This allows the endocytosis of the complex and subsequent injection of the A subunit into the cytosol of the host
cells. Here we report that the addition of an N-terminal His6-tag to different proteins increased their binding affinity to the
protective antigen (PA) PA63-channels, irrespective if they are related (C2I) or unrelated (gpJ, EDIN) to the AB7/8-family of
toxins. His6-EDIN exhibited voltage-dependent increase of the stability constant for binding by a factor of about 25 when
the trans-side corresponding to the cell interior was set to270 mV. Surprisingly, the C. botulinum toxin C2II-channel did not
share this feature of PA63. Cell-based experiments demonstrated that addition of an N-terminal His6-tag promoted also
intoxication of endothelial cells by C2I or EDIN via PA63. Our results revealed that addition of His6-tags to several factors
increase their binding properties to PA63 and enhance the property to intoxicate cells.
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Introduction
Gram-positive bacteria such as Bacillus anthracis and Clostridium
botulinum synthesize as most crucial virulence factors protein
toxins of the AB7/8 type. These toxins are composed of two
components which are nontoxic by themselves when added to
the external media of target cells [1]. One or more A-
components of the toxins feature intracellular enzymatic activity
and are responsible for the toxicity. The B-component binds to
cellular receptors or directly to the membrane and transports
the enzymatic component into the cell. Anthrax-toxin from B.
anthracis belongs to the AB7/8-type of toxins classified by a pore
forming B-component, protective antigen (PA) and two
enzymes, edema factor (EF) and lethal factor (LF). PA is an
83 kDa water soluble precursor, which has to be activated by
cleavage of a 20 kDa N-terminal part to form the functional
PA63-heptamers/octamers [2–5]. The proteolytic activation is
performed in vivo by cell bound furin. It allows pore formation
and injection of both enzymatic components EF and LF into
cells [6–9]. EF is an 89 kDa Ca2+- and calmodulin-dependent
adenylate cyclase which causes severe edema by uncontrolled
increase of the intracellular concentration of cAMP. LF is a
Zn2+-binding metalloprotease that cleaves mitogen-activated
protein kinase kinases (MAPK-kinases).
C. botulinum, well known for the production of potent
neurotoxins, also produces other protein toxins such as the binary
C2-toxin and the single-component C3 exoenzyme [10–12]. The
homologous pore forming component to PA63 of C2-toxin is C2II.
After proteolytic cleavage with trypsin (60 kDa) it forms
heptamer/octamerss that insert into biological and artificial
membranes at an acidic pH and promotes the translocation of
the 45 kDa enzymatic component C2I. Similar to anthrax-toxin a
receptor-mediated endocytocis of C2 is required for intoxication of
the cell [13,14]. C2I acts as an ADP-ribosyltransferase on
arginine177 of monomeric G-actin, causing disruption of the
actin cytoskeleton of eukaryotic cells [15,16].
The toxins of the AB-type represent simple but sophisticated
molecular syringes for protein delivery into target cells. This
means that they could be important systems for development of
new strategies for efficient injection of polypeptides into target
cells. Possible Trojan Horses could be binary toxins of the AB7/8
type such as anthrax- and C2-toxin [1]. The binding of the N-
terminal ends of the enzymatic components to the heptameric/
octameric channel formed by the binding components is followed
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by receptor-mediated endocytosis, acidification of the endosomes
and final release of the enzymatic components into the cytosol of
target cells, where they exert their enzymatic activities [3,17].
Interestingly, the amino-terminal part of LF is sufficient to confer
the ability to associate with PA63-heptamer/octamerss on LF. It
can be used to drive the translocation of unrelated polypeptides
fused to LF1–254 into target cells in a PA63-dependent manner
[18,19]. Although the enzymatic components of anthrax- and C2-
toxin differ considerably in their enzymatic activity and in their
primary structures as well, the binding components PA and C2II
share a significant overall sequence homology of about 35%,
which means that they are closely related in structure and
probably also in function [5,8,20,21]. There exist several structural
features that are important for the binding of channel blockers and
enzymes to be delivered into the target cells. One is the so-called
W(phenylalanine)-clamp - F427 in PA and F428 in C2II – which is
combined with two rings of seven negatively charged amino acids -
E399 and D428 in PA and E398 and D427 in C2II, respectively
[22,23]. These negatively charged amino acids seem to interact
with the positively charged N-terminal ends of the enzymatic
components [19,24,25]. Another interesting feature involved in
binding and transport of truncated and full-length effectors is the
alpha-clamp in PA [26,27]. This represents a big amphipathic cleft
on the surface of the PA63 heptamers/octamers, which plays an
important role in oligomer formation of PA63 and unfolding and
translocation of effectors [26,27].
Blanke et al. [19] have established that addition of His6-tag and
other polycationic presequences to diphtheria toxin A chain (DTA)
allows its injection into cells by PA63 binding component. The
observation that polycationic peptides at the N-terminal end of
DTA facilitate its import into the cytosol of a CHO-K1 cell line is
of particular interest [19]. Here we aimed at establishing whether
this effect of His6-tag could be generalized to other toxin
enzymatic components and quantify the involvement of His6-tag
on these toxin component interactions with PA63 in vivo and in
vitro. To study this we have investigated the influence of additional
charges on the N-terminal end on binding of the enzymatic factors
to the channels formed by PA63 and C2II. First results in the field
were found with polycationic peptides fused to EF, LF, LFN, EFN
and DTA [19,21]. Our results suggested that the binding of LF
and EF to C2II is possible and that C2I binds to PA63 in the black
lipid bilayer assay as well. The most significant result that was
observed was a preferential binding of His6-C2I, as compared to
C2I, to PA63. Interestingly, PA63 is able to transport His6-C2I into
target cells with a higher efficiency than C2I. We extended these
finding by demonstrating that a His6-tag fused to the N-terminal
end of the epidermal cell differentiation inhibitor (EDIN) of
Staphylococcus aureus also increases its affinity to PA63 and allows an
efficient PA63-dependent delivery of His6-EDIN in target cells. In
addition, the stability constant for binding of His6-EDIN and not
that of EDIN to PA63-channels was found to be highly voltage-
dependent, which could be one important factor for efficient
delivery of effectors via PA63 into target cells.
Experimental Procedures
Materials
Protective antigen encoding gene was cloned with BamHI-SacI
restriction sites into pET22 (Novagen) as previously described
[28]. The translocation-defective PA mutant F427A [22,29] was
constructed by site-directed mutagenesis using the Quick-
ChangeTM kit (Stratagene) according to the manufacturers
instructions. The PA-gene cloned in the plasmid pET19 (Novagen)
[30,31], was used as a template. The construct was confirmed by
DNA sequencing. The protein was expressed with an N-terminal
His6-tag in BL21 (DE3) (Novagen) and purified by HiTrap
chelating (Pharmacia) charged with Ni2+ ions.
C2I and C2II genes were PCR-amplified from genomic DNA of
Clostridium botulinum D strain 1873 and cloned into pET22
(Novagen) and pQE30 (Qiagen) expression plasmids with
BamHI-SacI restriction sites.
The plasmid coding for the chimera protein MBP-gpJ (maltose-
binding-protein attached to amino acids 684–1132 of Lambda
phage tail protein J) was a kind gift of Alain Charbit, Necker
Enfants Malade, Paris, France. Expression and purification of
MBP-gpJ was performed as described previously [32]. gpJ was
obtained by treatment of MBP-gpJ bound to starch column beads
(amylose-Sepharose, New England Biolabs) with factor Xa
(Invitrogen). His6-gpJ (684–1132) was obtained as described
previously [33].
The DNA encoding EDIN (NCBI M63917) was cloned into
pET28a vector using BamHI-EcoRI restriction site as described
previously [34]. Recombinant toxins containing His6-tags were
expressed in E. coli BL21 (DE3) and purified on a Chelating
Sepharose Fast Flow column previously chelated with nickel
(Amersham Biosciences) as recommended by the manufacturer.
Fractions containing toxin were pooled and dialyzed over night
against 250 mM NaCl and 25 mM Tris-HCl, pH 8. The N-
terminal His6-tag was removed by incubation with thrombin.
Nicked anthrax PA63 from B. anthracis was obtained from List
Biological Laboratories Inc., Campbell, CA. One mg of lyophi-
lized protein was dissolved in 1 ml 5 mM HEPES, 50 mM NaCl,
pH 7.5 complemented with 1.25% trehalose. Aliquots were stored
at 220uC. Channel formation by PA63 was stable for months
under these conditions.
Cell Culture and Biochemical Products
HUVECs (human umbilical vein endothelial cells, a human
primary cell line obtained from PromoCell) were grown in serum-
free medium (SFM) supplemented with 20% FBS (Invitrogen),
20 ng/ml basic ßFGF (Invitrogen), 10 ng/ml EGF (Invitrogen)
and 1 mg/ml heparin (Sigma-Aldrich) as described previously [35].
Monoclonal antibodies used were: anti-RhoA (BD Biosciences,
[clone 26C4]); anti- ß-actin (SIGMA, [clone AC9–74]); anti-His-
tag (Qiagen, [Penta-His]). Primary antibodies were visualized
using goat anti-mouse horseradish peroxidase-conjugated second-
ary antibodies (DakoCytomation), followed by chemiluminescence
detection ECL (GE Healthcare). Levels of active Rho were
determined by GST-rhotekin RBD pull-down that was modified
as described previously [35].
Immunofluorescence Studies
The experiments were performed on cells fixed in 4%
paraformaldehyde (SIGMA). Actin cytoskeleton was labelled using
FITC-conjugated phalloidin (SIGMA), as described in [36].
Immunosignals were analyzed with inverted microscope (EVOSfl,
AMG) using a 20X object lens.
Lipid Bilayer Experiments
Black lipid bilayer measurements were performed as described
previously [37]. The instrumentation consisted of a Teflon
chamber with two aqueous compartments connected by a small
circular hole. The hole had a surface area of about 0.4 mm2.
Membranes were formed by painting a 1% solution of diphytanoyl
phosphatidylcholine (Avanti Polar Lipids, Alabaster, AL) in n-
decane onto the hole. The aqueous salt solutions (Merck,
Darmstadt, Germany) were buffered with 10 mM MES-KOH to
pH 5.5 to pH 6. Control experiments revealed that the pH was
His-Tag Promoted Protein Delivery by PA into Cells
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stable during the time course of the experiments. The binding
components of the binary toxins were reconstituted into the lipid
bilayer membranes by adding concentrated solutions to the
aqueous phase on one side (the cis-side) of a black membrane.
The temperature was kept at 20uC throughout. Membrane
conductance was measured after application of a fixed membrane
potential with a pair of silver/silver chloride electrodes inserted
into the aqueous solutions on both sides of the membrane.
Membrane current was measured using a homemade current-to-
voltage converter combined with a Burr Brown operational
amplifier. The amplified signal was monitored on a storage
oscilloscope and recorded on a strip chart recorder.
Binding Experiments
The binding of the His-tagged proteins to the C2II-channel and
the binding component PA63 was investigated with titration
experiments similar to those performed previously to study the
binding of 4-aminoquinolones to the C2II- and PA63-channels and
EF and LF to the PA63-channel in single- or multi-channel
experiments [38–40]. The aqueous phase contained always
150 mM KCl, buffered with 10 mM MES-KOH to pH 5.5 to
pH 6. The C2II- and PA63-channels were reconstituted into lipid
bilayers. About 60 minutes after the addition of either activated
C2II or PA63 to the cis-side of the membrane, the rate of channel
insertion in the membranes was very small. Then concentrated
solutions of His-tagged proteins were added to the cis-side of the
membranes while stirring to allow equilibration. The results of the
titration experiments, i.e. the blockage of the channels, were
analyzed using Langmuir adsorption isotherms [21,41].
Fraction of blocked channels~
(Gmax-G(c))
Gmax
~
K :c
(K:cz1)
ð1Þ
The Fraction of closed channels as a function of the
concentration of the enzymatic components was analyzed using
Lineweaver-Burk (double reciprocal) plots.
1= Fraction of blocked channelsð Þ~ (K
:cz1)
K:c
~1z
1
K:c
ð2Þ
K is the stability constant for binding of the enzymatic
components of the binary toxins to the PA63- or C2II-channels.
The half saturation constant Ks is given by the inverse stability
constant 1/K.
Statistical Analysis
When assessing multiple groups, one-way ANOVA was used
followed by Bonferroni post hoc test with *p,0.05. Data are
presented as means 6 SEM. The statistical software used was
Prism 5.0 b.
Results
Interaction of PA63-pores with His6-C2I in Artificial Black
Lipid Bilayer Membranes
We compared the binding affinity of different proteins with and
without a His6-tag to the PA63- and C2II-channels. Taking into
account that positive charges seem to have a huge influence in
binding to the PA63-pore but only less to the C2II-pore [40,42], we
chose the enzymatic component C2I as the first substrate. In a
previous study we could show that it binds to PA63-pores and
could even be translocated into cells albeit with very low efficiency
at high C2I concentration [43]. We now addressed the question, if
binding and translocation are enhanced by addition of a His6-tag
to C2I.
The stability constants K (and the half-saturation constant Ks) for
the binding of His6-C2I to the PA63-channel were measured in
multichannel experiments, performed as described previously [39].
A receptor is required for the binding and oligomerization of PA63
on the surface of mammalian cells [8]. However, this is not
necessary for reconstitution of PA63-channels in artificial lipid
bilayers, where channel formation is obtained under mildly acidic
conditions [44]. 60 minutes after the addition of the protein to the
cis-side of the lipid bilayer, the rate of conductance increase had
slowed down considerably at an applied membrane potential of
20 mV. At that time, small amounts of a concentrated protein
solution were added to the cis-side of the membrane and the PA63-
induced membrane conductance decreased in a stepwise manner.
Figure 1A shows an experiment of this type in which increasing
concentrations of His6-C2I (arrows) were added to the cis-side of a
membrane containing about 300 PA63-channels. The membrane
conductance decreased as a function of the His6-C2I concentra-
tion. The data of Figure 1A and of similar experiments were
analyzed assuming Langmuir isotherms for binding (equation (1))
[39,41,45] Lineweaver-Burk (double reciprocal) plots were used to
calculate the stability constant K for binding as shown in Figure 1B
for the data of Figure 1A. The resulting straight corresponded to a
stability constant K of (3.9360.39)6107 M21 for His6-C2I binding
to PA63-pores (half saturation constant KS= 25 nM).
At least three individual experiments were used to calculate the
half saturation constants KS of C2I- and His6-C2I binding to the
PA63-channel. The average of the half-saturation constant Ks was
150 nM for C2I, whereas that for His6-C2I binding to PA63-
channels was 16 nM] in 150 mM KCl. This means that the half
saturation constant KS for binding of His6-C2I was roughly ten
times lower than that for C2I without His6-tag (Table 1). Titration
experiments with artificial bilayer membranes of the wildtype A-B
components C2II and C2I of C2-toxin revealed a half saturation
constant KS of 27 nM. Interestingly, a His6-tag attached to the N-
terminal end had no obvious effect on binding of C2I to C2II-
pores (KS=29 nM; Table 1).
Addition of His6-tag to C2I Potentiates its Transfer via
PA63
In further experiments we tested if addition of His6-tag to
C2I triggers its entry into cells via PA63-channels in vivo. C2I
acts as an ADP-ribosyltransferase, targeting cellular G-actin
[46]. Therefore, successful delivery of this enzymatic component
into target cells can be detected by disruption of the
cytoskeleton followed by rounding up and detachment of target
cells from the extracellular matrix, defined as intoxicated cells
[15]. HUVECs were intoxicated with C2I and His6-C2I driven
by PA63, as indicated, and the number of intoxicated cells was
directly assessed by counting (Fig. 2A). These results were
compared to that of native toxin combination C2I and C2II.
We observed a cytotoxic effect with the combination of His6-
C2I and PA63. No effect could be detected for C2I and PA63
under the same conditions. The specificity of this internalization
was verified by using a mutant of PA63: PA F427A. This
mutant is competent for receptor binding and internalization,
but defective in the pH dependent functions: pore formation
and ability to translocate bound ligands [47]. Intoxication of
cells with His6-C2I and PA F427A did not induce any cellular
effect (Fig. 2B). Thus, the increase of affinity between PA63 and
His-Tag Promoted Protein Delivery by PA into Cells
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C2I, upon addition of His6-tag to C2I allows His6-C2I to
efficiently intoxicate cells via PA63-channels.
His6-tags do not Facilitate Binding of EF and LF to C2II-
channels
To examine whether the N-terminal His6-tag of EF and LF
have a similar effect on binding kinetics to the C2II-channel, as
previously shown for His6-EF and His6-LF and PA63 [21], we
omitted the cleavage of the His6-tag after the affinity purification
and studied binding to C2II-channels. Interestingly, His6-EF and
His6-LF did not exhibit any significant changes of their affinity to
C2II-channels as compared to EF and LF (see Table 1). The half
saturation constants KS of the interactions between His6-EF and
His6-LF and the C2II-channels were 19 nM for His6-EF and
29 nM for His6-LF (Table 1).
Binding of His6-gpJ and gpJ Proteins to PA63- and C2II-
channels
The His6-tag had a remarkable influence on binding of
enzymatic components to the PA63-channel but not to the C2II-
channel. To check if this interaction was specific for the
presence of the His6-tag we performed titration experiment with
a His-tagged protein that is not related to the effectors EF, LF
or C2I. gpJ is a 447 amino acids C-terminal fragment of
protein J (amino acids 684–1131), which is responsible for
binding of bacteriophage Lambda to LamB on the surface of E.
coli K-12 [31]. His6-gpJ exhibited high affinity binding (block) to
the PA63-channel. The half saturation constant KS for binding of
His6-gpJ to PA63 was calculated to be 5.0 nM in 150 mM KCl,
10 mM MES-KOH, pH 6.0 (mean of three measurements)
(Table 1). Similar experiments with gpJ did not exploit any
Figure 1. Interaction of C2I with PA63 channels. A: Titration of PA63 induced membrane conductance with His6-C2I. The membrane was painted
from 1% (w/v) diphytanoyl phosphatidylcholine dissolved in n-decane. It contained about 300 PA63-channels. His6-C2I was added at the
concentrations shown at the top of the panel to the cis-side of the membrane. Finally, about 83% of the PA63-channels were blocked. The aqueous
phase contained 1 ng/ml activated PA63 (added only to the cis-side of the membrane), 150 mM KCl, 10 mM MES-KOH pH 6. The temperature was
20uC and the applied voltage was 20 mV. B: Lineweaver-Burk (double reciprocal) plot of the inhibition of the PA63-induced membrane conductance
by His6-C2I using equation (2). The fit was obtained by linear regression of the data points taken from Figure 1A and corresponds to a stability
constant K for His6-C2I binding to PA63 of (3.9360.39)610
7 M21 (r = 0.955; half saturation constant Ks=25 nM).
doi:10.1371/journal.pone.0046964.g001
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binding of gpJ to the PA63-channel. This implies half saturation
constants Ks of gpJ-binding to PA63 were much higher than
100 mM. We could not detect any substantial binding of His6-
gpJ nor of gpJ to the C2II-channel (Table 1). Our results reveal
the substantial role of the His6-tag at the N-terminal end of C2I
and gpJ for their binding to the PA63- but not to the C2II-
channel.
Binding of EDIN and His6-EDIN to PA63- and C2II-channels
Next, we tested whether PA63-pores bind and transport EDIN
of Staphylococcus aureus, as well as His6-EDIN. EDIN normally
enters host cells inefficiently by nonspecific macropinocytosis
and not by delivery systems considered in this study [28].
Previously, it has been shown that LF1–254-EDIN can enter cells
via PA63 [28]. EDIN is a Staphylococcus aureus exoenzyme with
ADP-ribosylating activity on RhoA. EDIN targets RhoA in cells
for inactivation producing actin cable disruption in target cells
[34]. Interestingly, we found that PA63-pores bound both EDIN
and His6-EDIN with half saturation constants that were
considerably lower than those reported before for the crossing
over of the AB7/8 types of toxin [43]. The half saturation
constant KS for EDIN binding to PA63-channels was on average
2.7 mM in 150 mM KCl, whereas this constant decreased to
0.7 mM for His6-EDIN. The results of these experiments are
summarized in Table 1 and demonstrate that EDIN without
His6-tag bound at low transmembrane voltage (5 mV) with a
roughly four-fold lower affinity to the PA63-channels than His6-
EDIN. When higher voltages were applied we noticed a
remarkable effect of voltage on His6-EDIN binding (see below).
The affinity of EDIN to the C2II-channels (KS=23 mM) was by
a factor of about eight-fold lower as compared to binding to the
PA63-channels. Surprisingly, we observed a considerable effect
when the His6-tag was attached to the N-terminal end of EDIN.
The half saturation constant dropped in this case to 0.9 mM for
its binding to C2II-pores (Table 1).
His6-tag Promotes EDIN Internalization via PA63-pores
We next verified the role of His6-tag in the uptake of EDIN into
cells. After purification the His6-tag was cleaved as described in the
material and methods section. We verified the cleavage by
immunoblotting the purified proteins using an antibody against
the His6-tag (Fig. 3A). The efficiency of RhoA targeting by EDIN
was assessed by GST-Rhotekin pull down of active RhoA (GTP-
bound RhoA). No effect was measured on cells challenged with
His6-EDIN alone up 10 mg/ml (Fig. 3B).
We then intoxicated cells with His6-EDIN in the presence and
absence of PA63. Strikingly, this revealed that the addition of PA63
together with His6-EDIN (10 mg/ml) increased the capacity of
EDIN to intoxicate cells. This led us to decipher the role of His6-
tag. Cells were intoxicated with PA63 together with EDIN or His6-
EDIN. This clearly established that addition of His6-tag to EDIN
in presence of PA63 produced a 78% decrease of RhoA activation
specifically (Fig. 3C). In conclusion, addition of His6-tag to EDIN
promotes its internalization via PA63 for cell intoxication.
Immunofluorescence Studies of HUVECs and PA63 with
EDIN and His6-EDIN
We next analyzed the actin cytoskeleton phenotype of cells
intoxicated with PA63+His6-EDIN and PA63+LFN-EDIN, as well
as EDIN alone or in combination with PA63 (Figure 4A). In all
cases we observed that intoxicated cells displayed a disruption of
filamentous actin and actin cables, as well as a undergo spreading,
as previously described (Figure 4A) [34,36]. In addition, intoxi-
cated cells displayed large transendothelial cell macroaperture
tunnels (TEM) (see Figure 4A). Induction of TEMs results from the
dose dependent inhibition of RhoA [34,36]. We thus further
determined the efficiency of cell intoxication, using different
combinations of toxin components by measure of the percentage
of cells displaying TEMs (Figure 4B). Most importantly, this
showed that addition of His6-tag to EDIN increases its capacity to
intoxicate cells in combination with PA63 at a concentration of
Table 1. Stability constants K and half saturation constants Ks for binding of proteins with and without His6-tags to membrane
channels formed by anthrax PA63 and C2II.
PA63 K [10
7 1/(Ms)] Ks [nM] K [10
7 1/(Ms)] Ks [nM]
Ratio KS/KS
without and with
His6-tag
with EF* 14.5 6.9 His6-EF* 62.5 0.16 43
LF* 36.2 2.8 His6-LF* 550 0.18 16
C2I 0.6860.42 150 His6-C2I 6.264.2 16 9.4
gpJ ,0.001 .100.000 His6-gpJ 2066.0 5.0 .20,000
EDIN 0.04060.011 2,700 His6-EDIN 0.1460.015 700 3.9
C2II K [107 1/(Ms)] Ks [nM] K [10
71/(Ms)] Ks [nM]
with EF** 7.7 13.0 His6-EF 5.261.6 19 0.68
LF** 2.0 49.9 His6-LF 3.461.9 29 1.7
C2I** 3.7 27.2 His6-C2I 3.960.52 29 0.94
gpJ ,0.001 .100,000 His6-gpJ ,0.001 .100,000 Not to determine
EDIN 0.004360.0007 23,000 His6-EDIN 0.1160.03 900 26
Stability constants K and half saturation constants Ks for the binding of His6-tagged and untagged EF, LF, C2I, gpJ or EDIN to PA63- or C2II-channels in lipid bilayer
membranes. The membranes were painted from 1% (w/v) diphytanoyl phosphatidylcholine dissolved in n-decane. The aqueous phase contained 150 mM KCl, buffered
to pH between 5.5 and 6 using 10 mM MES-KOH; T = 20uC. Measurements were performed at a membrane potential of 20 mV. The data represent the means (6 SD) of
at least three individual titration experiments. KS is the half saturation constant, i.e. KS= 1/K. Stability constants given in bold were adjusted to the voltage dependent
behavior of binding. (* taken from [21] ** taken from [43]).
doi:10.1371/journal.pone.0046964.t001
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10 mg/ml, whereas intoxication of HUVECS with LFN-EDIN
saturated already at 1 mg/ml (Figure 4B).
The Voltage Dependency of PA63-channels is Changed
when His6-EDIN is Bound to the Pore
PA63-channels exhibit a well described voltage dependency
[21]. If only added to the cis-side, PA63-induced conductivity
decreases when applied voltage is higher than +50 mV or lower
than 220 mV at the cis-side. It is also known that His6-EF bound
to the channel changes the voltage dependency [21]. When
different potentials were applied to membranes after the titration
of PA63-pores with EDIN, there was only little change in voltage
dependency of the channel (Fig. 5A). On the other hand, His6-
EDIN bound to PA63-channels induced dramatic responses even
at low positive voltages (Fig. 5B). Starting at +10 mV, the
conductivity decreased exponentially immediately after the onset
of the voltage with a voltage-dependent exponential relaxation
time. Its time constant decreased with higher positive potentials at
the cis-side (negative at the trans-side). This result indicated that
Figure 2. Efficiency of HUVEC intoxication by C2I and His6-C2I using PA63 compared to PA F427A mutant. HUVECs (5610
5 cells/
100 mm well) were intoxicated during 24 hours and the number of intoxicated cells (round cells) was assessed by counting floating cells. A: PA63 and
C2II at 5 mg/ml and C2I and His6-C2I at 2 mg/ml. One representative experiment showing mean values of 5 independent counting for each condition.
6 SEM *p,0.05 versus control condition. B: PA63 and PA F427A at 50 mg/ml and His6-C2I at 2 mg/ml. Data correspond to mean values of n= 5
experiments6 SEM, *p,0.05 versus control condition. The control corresponds to conditions without PA63. All experiments were performed with the
same batch of cells at the same time. The 3-fold increase of toxicity using 10-fold more PA63 was repeatedly measured.
doi:10.1371/journal.pone.0046964.g002
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channels, which were not blocked before by His6-EDIN at low
voltage bound this compound and closed as a result of the higher
voltage. This result suggested an increase of the stability constant
of binding up to very high voltages an effect that has already been
observed with full length EF [21].
The increase of the stability constant for binding could be
calculated from the data of Figures 5A and 5B and similar
experiments by dividing the initial current (which was a linear
function of voltage) by the stationary current after the exponential
relaxation and multiplying the ratio with the stability constant
derived at 5 mV. Figure 6 summarizes the effect of the positive
membrane potential on the stability constant K for EDIN and
His6-EDIN binding as a function of the voltage. Starting already
with 210 mV at the trans-side the stability constant K for His6-
EDIN binding started to increase and reached with about 60 to
70 mV a maximum. At that voltage K was roughly 25 times
greater than at 5 mV. For higher voltages the stability constant
saturated probably because of secondary effects of the high voltage
on the PA63-channel or on His6-EDIN binding. Figure 6 shows
also the effect of the positive membrane potential at the cis-side on
the stability constant K for EDIN binding to PA63-pores as a
function of the voltage. Interestingly, EDIN binding was only little
affected by voltage as Figure 6 clearly indicated.
Discussion
His6-tag Addition to Several Bacterial Factors Increased
the Protein Binding Affinity to PA63- but not to C2II-
channels
Recent studies demonstrated that negatively charged amino
acids in the vestibule of the PA63-channel play a crucial role in
binding of effector molecules [40,42]. Thus, it is possible that a
His6-tag, which adds positive charges under mildly acidic
conditions to the N-terminal end of His6-EF and His6-LF affects
binding and transport. This has indeed been shown for the native
combinations of EF+PA63 or LF+PA63 and the potential ion-ion
interaction discussed with EFN [21,39,48,49]. Recently, we could
Figure 3. His6-tag allows internalization of EDIN in endothelial cells through PA63. A: Upper panel: SDS-PAGE of recombinant His6-tagged
EDIN before (left) and after thrombin treatment (right). Lower panel: immunoblot anti–His6-tag on His6-tagged EDIN before and after cleavage by
thrombin. B, C: Immunoblots showing cellular levels of active RhoA (RhoA-GTP) in HUVECs determined by GST-Rhotekin RBD pulldown (labeled
RhoA-GTP). Cellular content of RhoA (Total RhoA) was assessed by anti-RhoA on 2% of total protein extracts. Immunoblot anti-actin antibody exhibits
equal protein loading. (B) Cells were intoxicated with different concentrations of His6-EDIN (1, 10 and 100 mg/ml) with and without 3 mg/ml of PA63,
as indicated. (C) Cells were intoxicated with 10 mg/ml His6-EDIN, 10 mg/ml EDIN, and 3 mg/ml PA63 as indicated.
doi:10.1371/journal.pone.0046964.g003
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Figure 4. Immunofluorescence studies of HUVECs treated with EDIN and His6-EDIN and PA63. A: HUVECs were intoxicated for 24 h with a
combination of PA63 3 mg/ml, His6-EDIN 10 mg/ml and LF1–254-EDIN (LFN-EDIN) 1 mg/ml, as indicated. Cells were fixed and actin cytoskeleton was
labelled using FITC-conjugated phalloidin. Bar = 10 mm. Arrows indicate transendothelial cell macroaperture tunnels (TEMs, transcellular tunnels). B:
Graph shows percentage of cells with toxin-induced transendothelial cell macroaperture tunnels (TEMs, transcellular tunnels). HUVECs were
intoxicated for 24 h with a combination of PA63 3 mg/ml, His6-EDIN or EDIN 10 mg/ml and LF1–254-EDIN (LFN-EDIN) 1 mg/ml, as indicated on the graph
legend. Data correspond to means 6 SEM (n= 3, 400 cells per condition).
doi:10.1371/journal.pone.0046964.g004
Figure 5. Voltage dependency of PA63-channels in the presence of EDIN and His6-EDIN. A: Current response of PA63-channels in presence
of EDIN. Voltage pulses between +20 and +70 mV were applied to a diphytanoyl phosphatidylcholine/n-decane membrane in the presence of PA63-
pores and EDIN (both added only to the cis side of the membrane). The aqueous phase contained 150 mM KCl, 10 mM MES-KOH, pH 6. The
temperature was 20uC. B: Current response of PA63 channels in the presence of His6-EDIN. Voltage pulses between +10 and +90 mV were applied to a
diphytanoyl phosphatidylcholine/n-decane membrane in the presence of PA63-pores and His6-EDIN (both added only to the cis side of the
membrane). The aqueous phase contained 150 mM KCl, 10 mM MES-KOH, pH 6. The temperature was 20uC. Note the change of the scale (Arrow).
doi:10.1371/journal.pone.0046964.g005
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show that C2I binds to PA63 and may even be transported into
target cells albeit at high PA63 concentration and with very low
efficiency compared with the native combination of C2I with C2II
[43]. Here we studied the cross reactivity of anthrax- and C2-toxin
in more detail and found a strong relation between binding affinity
and the presence of a His6-tag at the N-terminal end of the
enzymatic components. The addition of positive charges at the N-
terminal end of C2I (due to the partially charged histidines)
enhanced binding to and translocation into target cells via PA63-
pores and agreed very well with the findings previously reported
for His6-tags attached to EF and to LF [21,39]. Binding to PA63-
channels was found to be strongly enhanced for the three
enzymatic components EF, LF and C2I when they contained a
His6-tag at the N–terminal end.
Interestingly, we did not observe major effects if these His6-
tagged proteins were combined with C2II-channels. The results of
binding experiments with His6-EF and His6-LF to C2II-channels
suggested that the increased positive charge at the N-terminal end,
due to the partially charged histidines, did not increase the binding
of these enzymatic components to the C2II-channels. These results
definitely imply that binding of the enzymatic components to
PA63-channels occurs in a different way than binding to C2II-
channels.
To gain deeper insight in the influence of N-terminal His6-tags
on binding of proteins to PA63-channels we choose a protein, gpJ,
that was not related to any of the enzymatic components used in
this study [33]. As expected, we did not observe any binding of gpJ
to PA63- or C2II-channels (KS .100 mM). However, binding was
observed when a His6-tag was attached to the N-terminal end of
gpJ. This protein had a half-saturation constant for binding to the
PA63-channels of 5 nM, which suggested that the affinity of His6-
gpJ to PA63-channels was almost the same as that of LF and EF
[21,39]. This means that the affinity increase is mainly determined
by the positive charges of the His6-tag. It is interesting to note that
His6-gpJ did accordingly not interact with C2II-channels; reveal-
ing again a somewhat different process for binding of His6-tagged
proteins to PA63-channels than to C2II-channels. However, it is
not clear if His6-gpJ could also be imported via PA63 into target
cells because this protein has no intracellular enzymatic activity
[320].
Influence of the His6-tag on Uptake of EF, LF and C2I into
Cells
The binding step is a prerequisite, but not sufficient for the
delivery of enzymatic subunits into target cells. Thus, in order to
complement the results of binding studies we went on to
investigate the translocation by analyzing the enzymatic activity
in a cellular system. We verified that a His6-tag attached to the N-
terminal end of C2I increased its transport by PA63-channels,
which correlates with the difference of 10-fold measured between
the stability constants for binding of C2I and His6-C2I. Some
difference in transport was observed by using EF or LF with or
without a His6-tag in combination with PA63-channels. In
particular, we could demonstrate that addition of a His6-tag
promoted uptake of LT (PA + His6-LF) into HUVECs (data not
shown). This result is in agreement with the increased affinity of
EF and LF to PA63-heptamer/octamerss when they contain a
His6-tag at the N-terminus [21,23].
Although the binding of EFN and LFN (truncated forms of EF
and LF) to the PA63–channel is substantially weaker as compared
to wild-type enzymatic components [42], these proteins interact
with high affinity with the PA63-channels and are accordingly
transported into the cell [48,50,51]. Similarly, short stretches of
positively charged amino acids attached to the N-terminal end of
foreign proteins can lead to a PA63-dependent delivery as it has
been demonstrated for the addition of polycationic peptides to the
N-terminus of the enzymatic A chain of diphtheria toxin (DTA;
residues 1–193) or for LF1–254-EDIN [19,28].
Figure 6. Correlation of affinity constant K and voltage dependence of PA63-channels in presence of EDIN and His6-EDIN. The
stability constants of EDIN and His6-EDIN binding to the PA63-channel are given as a function of the applied membrane potential taken from
experiments similar to that shown in Fig. 5 A/B. Means of three experiments are shown.
doi:10.1371/journal.pone.0046964.g006
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Bound His6-EDIN or EDIN Causes a Difference in Voltage-
dependency of PA63-pores
Experiments with EDIN of S. aureus were performed to gain
deeper insight in the binding and translocation processes through
PA63-channels and its His6-tag dependence. Surprisingly, black
lipid bilayer experiments displayed that not only His6-EDIN but
also EDIN itself bound to PA63-channels. The affinity of EDIN
and His6-EDIN to the PA63-channels was in the same range at low
trans-membrane potentials because His6-EDIN exhibited only a
three times higher affinity for binding to the PA63-channels than
EDIN. Under normal conditions the PA63-channels only close for
higher negative voltages applied to the cis-side [21]. For positive
potential the channels are open and do not show a voltage-
dependent closure until 100–150 mV [21]. However, His6-EDIN
binding to the PA63-channels showed an extremely high voltage-
dependence when the voltage was positive at the cis-side of the
membrane indicating that the potential pulled His6-EDIN into the
channels. As a result the stability constant for binding of His6-
EDIN to the PA63-channels increased at voltages of +70 mV at the
cis-side (corresponding to 270 mV at the trans-side) by a factor of
roughly 25 as compared to zero voltage. Bound EDIN displayed
an only minor voltage-dependence. This means that the His6-tag is
responsible for the binding EDIN and gpJ to the PA63-channels.
Binding is essential for translocation because it is the first step of
the whole process (see below).
The PA63-channel Transports His6-C2I and His6-EDIN into
the HUVECs
EDIN uptake into target cells can easily be detected because it
decreases RhoA activity. Import of EDIN via PA63-channels could
not be observed. Import was however, possible when EDIN
contained a His6-tag. This finding demonstrated that His6-tag
itself provides the ability for proteins to be transported into cells
through PA63-pores. This effect was presumably promoted by the
voltage-dependence of His6-EDIN binding to the PA63-channels.
Biological membranes are polarized to about 260 mV to
270 mV (inside negative). This may explain the much higher
effect of His6-EDIN compared to EDIN on cells described above.
In any case it clearly indicates the potentiating effect of a His6-tag
and applied voltage on binding and translocation of protein
molecules to PA63-channels. Summarizing the results, there
definitely exists a difference in the binding and translocation
mechanism between the two very homologous binding compo-
nents PA63 and C2II of anthrax- and C2-toxin. Obviously, this
distinction is induced by unequal binding surroundings inside the
head region of the two protein channels.
The amino acids responsible for binding within the N-terminal
end of the enzymatic components are still a matter of debate,
although there is clear evidence that positively charged amino
acids are involved in binding, forming salt bridges between the
enzymatic components and the heptamers/octamers. In a recent
study it has been shown that besides the Phi-clamp also the such-
called alpha-clamp is also involved in effector binding, unfolding
and translocation in combination with PA63 [26,27]. This alpha-
clamp is composed of hydrophobic and aromatic residues, such as
F202 and P205 and forms a deep amphipathic cleft on the surface
of the PA63 oligomer [26,27]. It is also possible that R178
contributes to effector binding but not to translocation. However,
the alpha-clamp does not seem to be very specific because of its
broad substrate specificity and non-specific polypeptide binding
activity [26]. It is noteworthy that amino acids of the alpha-clamp
do not appear to be preserved in C2II because PA R178, PA F202
and PA P205 correspond to C2II T169, C2II W193 and C2II
K196 [26,27]. This could mean that the design of the alpha-clamp
in C2II if it existed has a different structure or is absent.
The positively charged N-termini of the enzymes play
presumably a crucial role, because quaternary ammonium ions
and 4-aminoquinolones show PA63 and C2II channel block in
lipid bilayer experiments [38,40,44,52]. Both channels show a
high selectivity for cations, i.e. cations have a strong influence on
the single channel conductance as compared to anions [53,54].
This means that negative charged amino acids play a crucial role
in the binding and constriction region of the PA63-channels, where
they form two rings of seven putative negatively charged amino
acids in the vestibule of this pore (E398 and D426). Similarly, the
channel lumen contains additional three rings of seven possibly
negatively charged groups (E302, E308 and D315). Some of these
charges cannot be found in the C2II-channel lumen, resulting in
minor effects of His6-tag on binding and transport. However,
transport into cells seems to be possible with C2II-pores and when
N-terminal parts of C2I are coupled to foreign proteins [1,55,56].
The most interesting result of this study was that we could use the
anthrax PA63-channels to deliver into cells a polypeptide
completely unrelated to the AB7/8-type of toxins. In fact, we here
provide evidence that the His6-tag addition on EDIN allows its
entry in target cells, in a PA63-dependent manner. On the other
hand, we would like to stress the point that the natural uptake of
EDIN occurs very slowly at very high EDIN concentration
(100 mg/ml: see Figure 3C). Nevertheless, here our data support
the idea that it seems possible to design a very simple
transportation system using His6-tags on proteins unrelated to
the AB7/8-family and PA63-channels for biological purpose.
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